November 10-15

The official news source of

ACR Convergence 2023

San Diego, CA

  • Understanding comorbidities crucial in care of lupus patients

    Understanding comorbidities crucial in care of lupus patients

    A panel of experts, including Meenakshi Jolly, MD, MS, will discuss various issues involved in the management and treatment of lupus patients, including comorbidities that affect lupus patients and how to monitor for them, the role of patient-reported outcomes, and the factors that contribute to treatment adherence in lupus patients.

  • Better business knowledge boosts practice performance

    Better business knowledge boosts practice performance

    Valora Gurganious, MBA, CHBC, has spent decades helping clients understand the business side of their practice. Her session will help attendees navigate the strategies and concepts that can help build a practice that is as successful financially as it is clinically.

  • Sign up for the ACR’s RISE Registry and receive many quality reporting benefits

    Participation in a Qualified Clinical Data Registry (QCDR) such as the RISE Registry allows participants to meet quality reporting requirements through a seamless reporting process.

  • Keeping with the times: The 2016 Commemorative Gout Print

    Keeping with the times: The 2016 Commemorative Gout Print

    The Rheumatology Research Foundation is offering the latest in the Rodnan Commemorative Gout Print series for sale this year at the ACR Discovery

  • Research conferences focus on lung, immune-mediated disease

    The ACR’s Committee on Research put together an exceptional cadre of medical experts in a variety of disciplines who were part of the ACR’s Basic Research Conference and Clinical Research Conference on Friday and Saturday.

  • Thank You for the Support!

    In addition to the support provided for the 2016 ACR/ARHP Annual Meeting, the ACR, the ARHP, and the Foundation wish to thank the following organizations for providing support for activities and programs throughout the year.

  • JAK family breakthroughs show promise in rheumatology treatment

    JAK family breakthroughs show promise in rheumatology treatment

    “Some clinicians know about the JAK inhibitors, but it’s new to many,” said John O’Shea, MD. “The first member of this class, tofacitinib, was approved in 2012, but it’s a very fast-moving field with multiple new agents being studied.”

  • MACRA to transform rheumatology practices

    MACRA to transform rheumatology practices

    Everything about the way you practice rheumatology changes on Jan. 1, 2017. “We will have to re-evaluate the practice of rheumatology to adapt to upcoming changes in our compensation,” said Douglas Graham, MD.

  • New research strengthens  autoimmunity-microbiome link

    New research strengthens autoimmunity-microbiome link

    Noah Wolcott Palm, PhD, Assistant Professor of Immunobiology and a member of the Human and Translational Immunology Program at Yale University School of Medicine, said that a large amount of microbiota-profiling data has been accumulated in the six years that microbiome sessions have been held at the Annual Meeting.

  • Researchers continue to uncover more RA-related metabolic processes

    Researchers continue to uncover more RA-related metabolic processes

    Luke O’Neill, PhD, will explore the converging worlds of inflammation and metabolism during a State-of-the-Art Lecture on Immuno-Metabolism: Energetics and Inflammation.